Edit |   |
---|---|
Antigenic Specificity | CD30, Human (Iratumumab biosimilar) |
Clone | Iratumumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IP, IF, FuncS, FCM, Neut, ELISA, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD30 Recombinant Antibody (Iratumumab). Iratumumab is a human monoclonal antibody used in the treatment of oncological diseases such as relapsed refractory CD30-positive lymphoma including Hodgkin's disease. This drug was developed by Medarex, which was later acquired by Bristol-Myers Squibb. |
Immunogen | n/a |
Other Names | Anti-CD30 Recombinant Antibody, Research Grade Iratumumab, Anti-Human CD30 Recombinant Antibody(Iratumumab), MDX-060, Antibody Drug Analogues, Monoclonal Antibody, YR1162, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 640735-09-7 |
Catalog # | YR1162 |
Price | please inquire |
Order / More Info | CD30, Human (Iratumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |